Polyamine inhibition of estrogen receptor (ER) DNA-binding and ligand-binding functions

[1]  C. Benz,et al.  Human breast tumors containing non-DNA-binding immunoreactive (67 kDa) estrogen receptor , 2004, Breast Cancer Research and Treatment.

[2]  T. Agthoven.  Mechanisms of Hormone Resistance in Breast Cancer , 1998 .

[3]  C. Osborne,et al.  Comparison of estrogen receptor DNA binding in untreated and acquired antiestrogen-resistant human breast tumors. , 1997, Cancer research.

[4]  J. Hériché,et al.  Binding of Polyamines to an Autonomous Domain of the Regulatory Subunit of Protein Kinase CK2 Induces a Conformational Change in the Holoenzyme , 1997, The Journal of Biological Chemistry.

[5]  T. Sun,et al.  Regulation of K3 keratin gene transcription by Sp1 and AP-2 in differentiating rabbit corneal epithelial cells , 1997, Molecular and cellular biology.

[6]  P. Crooks,et al.  The potential of a novel polyamine transport inhibitor in cancer chemotherapy. , 1996, The Journal of pharmacology and experimental therapeutics.

[7]  E. Gerner,et al.  Growth arrest- and polyamine-dependent expression of spermidine/spermine N1-acetyltransferase in human tumor cells. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[8]  R. Poulin,et al.  Permissive role of polyamines in the cooperative action of estrogens and insulin or insulin-like growth factor I on human breast cancer cell growth. , 1996, The Journal of clinical endocrinology and metabolism.

[9]  L. Demers,et al.  Isolation and characterization of human breast cancer cells overexpressing S-adenosylmethionine decarboxylase. , 1995, Cancer letters.

[10]  M. Gallo,et al.  Polyamine-mediated conformational perturbations in DNA alter the binding of estrogen receptor to poly(dG-m5dC).poly(dG-m5dC) and a plasmid containing the estrogen response element , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[11]  C. Benz,et al.  Gene diagnostics provide new insights into breast cancer prognosis and therapy. , 1995, Gene.

[12]  A. Manni,et al.  Involvement of the polyamine pathway in breast cancer progression. , 1995, Cancer letters.

[13]  K. Calame,et al.  Polyamines alter sequence-specific DNA-protein interactions. , 1995, Nucleic acids research.

[14]  D. Heitjan,et al.  Phenotypic features of breast cancer cells overexpressing ornithine‐decarboxylase , 1995, Journal of cellular physiology.

[15]  S. Hilsenbeck,et al.  Relationship of clone 4 estrogen receptor variant messenger RNA expression to some known prognostic variables in human breast cancer. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  T. Williams,et al.  The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Dowsett,et al.  Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer. , 1995, Cancer research.

[18]  C. Benz,et al.  Screening and characterization of estrogenic activity from a hydroxystilbene library. , 1995, Chemistry & biology.

[19]  K. Hsu.  Modulation of the nicotinic acetylcholine receptor channels by spermine in Xenopus muscle cell culture , 1994, Neuroscience Letters.

[20]  A. Brown,et al.  Spermine and spermidine as gating molecules for inward rectifier K+ channels. , 1994, Science.

[21]  T. Thomas,et al.  Polyamine-induced changes in the sedimentation profile and DNA binding of aryl hydrocarbon receptor. , 1994, Toxicology letters.

[22]  R. Maki,et al.  Binding of an ETS-related protein within the DNase I hypersensitive site of the HER2/neu promoter in human breast cancer cells. , 1994, The Journal of biological chemistry.

[23]  G. T. Budd,et al.  Estrogen receptor mutations in tamoxifen-resistant breast cancer. , 1994, Cancer research.

[24]  M. Bennett,et al.  Splice variants of the N-methyl-D-aspartate receptor NR1 identify domains involved in regulation by polyamines and protein kinase C. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Tomikazu Sasaki,et al.  Spermine-Induced Conformational Changes of a Synthetic Peptide , 1993 .

[26]  T. Thomas,et al.  Structural specificity of polyamines in modulating the binding of estrogen receptor to potential Z-DNA forming sequences. , 1993, Journal of receptor research.

[27]  J. Baxter,et al.  The limits of the cellular capacity to mediate an estrogen response. , 1992, Molecular endocrinology.

[28]  W. McGuire,et al.  Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors. , 1992, Cancer research.

[29]  C. Benz,et al.  Truncated forms of DNA-binding estrogen receptors in human breast cancer. , 1991, The Journal of clinical investigation.

[30]  J. Seibold,et al.  Restoration of the DNA binding activity of estrogen receptor in MRL-lpr/lpr mice by a polyamine biosynthesis inhibitor. , 1991, Arthritis and rheumatism.

[31]  L. Murphy.  Estrogen receptor variants in human breast cancer , 1990, Molecular and Cellular Endocrinology.

[32]  J. Schwabe,et al.  Solution structure of the DNA-binding domain of the oestrogen receptor. , 1990, Nature.

[33]  F. Studier,et al.  Use of T7 RNA polymerase to direct expression of cloned genes. , 1990, Methods in enzymology.

[34]  W C Johnson,et al.  Protein secondary structure and circular dichroism: A practical guide , 1990, Proteins.

[35]  A. K. Ganguly,et al.  Polyamines in relation to human breast, rectal and squamous cell carcinoma. , 1988, Cancer letters.

[36]  T. Thomas,et al.  Modulation of the binding of progesterone receptor to DNA by polyamines. , 1988, Cancer research.

[37]  A. Pegg,et al.  Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. , 1988, Cancer research.

[38]  L. C. Teixeira,et al.  Estrogen receptors in breast cancer ‐ therapeutic response to the treatment of recurrences , 1987, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[39]  H. Wallace,et al.  Polyamines in breast cancer , 1984, The British journal of surgery.